معرفی
Anna Long is a researcher at Newcastle University's College of Medicine and Health, Department of Oncology. Her work focuses on cancer biology, tumor microenvironment dynamics, and biomarker discovery across multiple malignancies.
- Key research areas: oncology, tumor microenvironment, biomarker development
- Recent publications (2012–2024) span pancreatic cancer, colorectal cancer, lymphoma, and osteosarcoma
- 2024 publication introduces PREDICTR-OPC, a multivariable classifier for oropharyngeal cancer treatment escalation
- Contributes to immunology research in ulcerative colitis and graft-versus-host disease
Her article analysis reveals trends in:
- Metabolic regulation (lactate dehydrogenase, monocarboxylate transporters)
- Cytokine signaling (interleukin-22, CRF secretion)
- Biomarker validation (microsatellite instability, NRAS-BRAF mutations)
- Integrin biology in inflammatory diseases
- Prognostic modeling in solid tumors
- Therapeutic targeting of tumor microenvironment components
۰مقاله منتشرشده
